Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 95 of 124)
- Relevance
  Sort by

Autism Spectrum Disorders Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Rare Neurological Disease Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Anticoagulants Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5883EUR$5,999USD£4,902GBP

Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Brazil

From

€3285EUR$3,350USD£2,737GBP

France Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
77 Pages
France

From

€3285EUR$3,350USD£2,737GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Germany Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
75 Pages
Germany

From

€3285EUR$3,350USD£2,737GBP

Mexico Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
74 Pages
Mexico

From

€3285EUR$3,350USD£2,737GBP

Japan Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
73 Pages
Japan

From

€3285EUR$3,350USD£2,737GBP

Israel Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
76 Pages
Israel

From

€3285EUR$3,350USD£2,737GBP

Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

 Report
September 2022
82 Pages
Turkey

From

€3285EUR$3,350USD£2,737GBP

Vasculitis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
119 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
115 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
100 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Anticoagulants Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
120 Pages
Global

From

€4413EUR$4,500USD£3,677GBP

Middle East And Africa Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

 Report
May 2023
79 Pages
Middle East, Africa

From

€2133EUR$2,175USD£1,777GBP

Drug Discovery Services Global Market Report 2024

 Report
February 2024
200 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

GLP-1 Receptor Agonist Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Neurofibromatosis Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Neuralgia Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

2,461 Results (Page 95 of 124)
- 1
- 93
- 94
- 95
- 96
- 97

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.